期刊文献+

抗人甲胎蛋白单克隆抗体的制备及双抗体夹心ELISA检测技术的建立 被引量:3

Preparation of monoclonal antibodies against hAFP and development of mAb-based sandwich ELISA
下载PDF
导出
摘要 目的:制备、筛选多株具有商用价值的可配对的高特异性、高亲和力的抗人甲胎蛋白(hAFP)单克隆抗体,初步建立双抗体夹心 ELISA 检测方法。方法通过经典的淋巴细胞杂交瘤技术筛选分泌抗 hAFP单抗的杂交瘤细胞株;对筛选所得单抗的特性进行鉴定分析;双抗体夹心 ELISA 法筛选最佳配对抗体;初步建立DAS-ELISA 检测方法并检测血样,绘制其标准检测曲线并与进口试剂盒比较。结果共获得12株稳定分泌抗 hAFP 单抗的杂交瘤细胞株,其中 Ab 1-Ab 55株单抗的腹水效价均高于600万, Ab 5的效价高达3000万;特异性鉴定结果表明 Ab 1-Ab 5均能够特异识别天然 hAFP 分子,但 Ab 5与人血清白蛋白(HSA)存在较强交叉反应;抗体配对实验共筛选出5对(Ab 1/HRP-Ab 2、Ab 1/HRP-Ab 4、Ab 3/HRP-Ab 2、Ab 3/HRP-Ab 4和 Ab 4/HRP-Ab 1)能够满足 hAFP 检测要求且无交叉反应的配对抗体,最终确定 Ab 1+ Ab 3/HRP-Ab 2和 Ab 1+Ab 3/HRP-Ab 4为最佳配对组合;利用最佳配对抗体组合建立标准检测曲线,其线性检测范围为5-250 ng/ml,最低检测限2 ng/ml,检测上限400 ng/ml,优于进口试剂盒的线性范围5-200 ng/ml 和最低检测限5 ng/ml;样检结果显示自制试剂盒的阳性血清检测准确率99.2%(119/120例),阴性血清准确率100%(40/40例)。结论筛选获得的4株高亲和力、高特异性抗 hAFP 单抗均可应用于 DAS-ELISA 试剂盒的研制,Ab 1和 Ab 3适合作为捕获抗体,Ab 2和 Ab 4适合作检测抗体;自制试剂盒的线性检测范围和最低检测限均优于进口试剂盒,表明具有商用价值。 Objective To prepare several hAFP-specific monoclonal antibodies with high specificity and high affinity. To screen antibody pairs with potential commercial value from these mAbs and to develop a sandwich enzyme-linked immunosorbent assay (DAS-ELISA) for the detection of hAFP. Methods mAbs were prepared using the classic hybridoma fusion method, and the specificity of mAb was identified and analyzed. Using DAS-ELISA, the best antibody pair was selected from the mAbs. DAS-ELISA was optimized and compared to an ABCam ELISA kit. Then the initially self-made kit was used to detect a total of 160 samples (including 120 positive and 40 negative serums). Results A total of 12 mAbs was prepared and 5 of them had very high affinities. The titers of ascites of both Ab 1-Ab 5 were less than 1:6 million and Ab 5 had the best titer:1:30 million. Both Ab 1-Ab 5 could recognize the natural hAFP specifically, but Ab 5 had cross-reaction with HSA. In the selected antibody pairs, Ab 1/HRP-Ab 2, Ab 1/HRP-Ab 4, Ab 3/HRP-Ab 2, Ab 3/HRP-Ab 4 and Ab 4/HRP-Ab 1 were identified to be capable of application. Ab 1+Ab 3/HRP-Ab 2 and Ab 1+Ab 3/HRP-Ab 4 were identified as the best antibody pairs to establish the DAS-ELISA kit. The self-made kit had better linear scale of detection (5-250 ng/ml) than that of ABCam kit (5-200 ng/ml), and better limitation of detection (2 ng/ml) than that of ABCam (5 ng/ml). The self-made kit also showed good results in detecting the samples with accuracies of 99.2%(119/120) in positive serums and 100%(40/40) in negative serums. Conclusion 4 mAbs ( including capture mAbs Ab 1 and Ab 3 and detection mAbs Ab 2 and Ab 4) with high affinity and specificity are used in developing the DAS-ELISA kit. The better linear scale and limitation of detection also suggest that this kit would have good commercial value.
出处 《中国医药生物技术》 2014年第4期268-272,共5页 Chinese Medicinal Biotechnology
基金 广东省战略性新兴产业核心技术攻关项目"免疫荧光定量快速检测技术在重大疾病检测中的应用"(2012A080800007)
关键词 甲胎蛋白类 抗体 单克隆 双抗体夹心 ELISA Alpha-fetoproteins Antibodies, monoclonal Sandwich enzyme-linked immunosorbent assay
  • 相关文献

参考文献11

  • 1Mizejewski GJ. New insights into AFP structure and function: potential biomedical applications. Orlando: Academic Press, 1985: 5-34.
  • 2Deutsch HF. Chemistry and biology of alpha-fetoprotein. Adv Cancer Res, 1991, 56:253-312.
  • 3Tatarinov YS. Content of embryo-specific alpha-globulin in the blood serum of the human fetus, newborn, and adult man in primary cancer of the liver. Vop Khim SSR, 1965, 11:20-24.
  • 4Brock D J, Sutcliffe RG. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet, 1972, 2(7770):197-199.
  • 5Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv, 2003, 58(12):804-826.
  • 6Mizejewski GJ. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther, 2002, 2(6):709-735.
  • 7汤钊猷.肝癌临床研究的进展与21世纪的展望[J].上海医科大学学报,1997,24(5):323-326. 被引量:19
  • 8Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology, 2002, 35(3):519-524.
  • 9孔君,刘箐,韩跃武,王天昌,刘金芝.单克隆抗体制备技术的最新进展及应用前景[J].免疫学杂志,2011,27(2):170-173. 被引量:46
  • 10Porstmann B, Avrameas S, Ternynck T, et al. An antibody chimera technique applied to enzyme immunoassay for human alpha-1- fetoprotein with monoclonal and polyclonal antibodies. J Immunol Methods, 1984, 66(1):179-185.

二级参考文献27

  • 1朱平.淋巴瘤的单克隆抗体治疗[J].中国医药生物技术,2006,1(1):65-68. 被引量:1
  • 2何忠效.浅谈单克隆抗体[J].生物学通报,2004,39(9):1-4. 被引量:4
  • 3朱学泰,谢溱,马瑞君.单克隆抗体制备技术研究进展[J].甘肃科技,2005,21(3):108-109. 被引量:16
  • 4李莉,王丽花,孔宪涛.单克隆抗体治疗的过去、现在和未来[J].免疫学杂志,2005,21(B06):13-16. 被引量:2
  • 5张爱华,余模松.噬菌体抗体库技术[J].国际生物制品学杂志,2006,29(1):13-16. 被引量:6
  • 6Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of Predefined specificity [J]. Nature, 1975, 256: 495-497.
  • 7Weiner, Louis M. Fully Human Therapeutic Monoclonal Antibodies[J]. Journal of Immunotherapy, 2006, 29(29): 1-9.
  • 8Roguska MA, Pedersen JT, Keddy CA, et al. Humanization of murine monoclonal antibodies through variable domain resurfacing [J]. Proe Natl Acad Sei USA,1994, 91 (3): 969-973.
  • 9Roguska MA, Pedersen JT, Herry A, et al. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing [J]. Protein Eng,1996, 9: 895-904.
  • 10Verboeyen M, Milstein C, Winter G. Reshaping human antibodies: Grafting an antilysozyme activity [J]. Science, 1988, 239: 1534-1536.

共引文献64

同被引文献16

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部